A Study to Evaluate the Efficacy and Safety of Belimumab Administered in Combination With Rituximab to Adult Subjects With Systemic Lupus Erythematosus (SLE) - BLISS-BELIEVE

Condition:   Systemic Lupus Erythematosus Interventions:   Drug: Belimumab;   Drug: Rituximab;   Drug: Rituximab-placebo;   Drug: Standard therapy (Including Immunosuppressants);   Drug: Standard therapy (Excluding Immunosuppressants);   Drug: Steriod Taper Sponsor:   GlaxoSmithKline Not yet recruiting

Source: ClinicalTrials.gov - October 18, 2017 Category: Research Source Type: clinical trials